A New Look at LDL and Cognitive Health
We often hear about bad cholesterol—low-density lipoprotein cholesterol (LDL-C)—as a major cause of heart disease. But what about its role in brain health? A new study from a large university hospital network in South Korea helps clarify the link between LDL-C levels and dementia risk. The results are both surprising and reassuring.
The Study at a Glance
Researchers analyzed data from 11 university hospitals using a shared clinical data model. They compared individuals with low LDL-C (<70 mg/dL) to those with high LDL-C (>130 mg/dL). All participants were free of dementia at the start and followed for cognitive outcomes.
The total matched cohort included 108,980 individuals.
- Primary Outcome: All-cause dementia
- Secondary Outcome: Alzheimer’s disease-related dementia (ADRD)
Statin use was also tracked to see if cholesterol-lowering therapy had additional effects.
Key Findings
1. Low LDL-C Strongly Reduces Dementia Risk
People with LDL-C levels below 70 mg/dL had:
- 26% lower risk of developing dementia
- 28% lower risk of Alzheimer’s-related dementia
Even more striking, those with LDL-C below 55 mg/dL showed:
- 18% lower risk for both all-cause dementia and ADRD
2. Statins Offer Extra Protection
Among those with LDL-C <70 mg/dL:
- Statin users had a 13% lower dementia risk
- 12% lower risk of ADRD compared to non-users
These benefits held even after careful adjustment for other health differences using propensity score matching.
| LDL-C Level | Dementia Risk | Alzheimer’s-Related Dementia (ADRD) Risk | Impact of Statin Use |
|---|---|---|---|
| >130 mg/dL | Baseline | Baseline | Baseline |
| <70 mg/dL | ↓ 26% | ↓ 28% | ↓ 13% (all-cause dementia), ↓ 12% (ADRD) |
| <55 mg/dL | ↓ 18% | ↓ 18% | Not specified |
What Does This Mean for You?
These findings challenge the outdated fear that low cholesterol—or statin use—might impair brain function. In fact, the opposite appears true. Maintaining LDL-C below 70 mg/dL, especially when supported by statin therapy, may significantly reduce your risk of cognitive decline.
Why Holistic, Individualized Care Matters
Not everyone benefits from the same LDL target. This is where personalized lipid care shines. In my Montgomery County, Maryland practice, we manage cholesterol thoughtfully—from multiple angles. We consider your heart, brain, hormones, metabolism, and family history. This common-sense approach aims not just to lower LDL, but to optimize your health over decades.
Low LDL isn’t just about avoiding heart attacks—it may also be part of a long-term strategy to preserve memory, clarity, and independence as we age.
Final Takeaway
Lowering LDL-C, even to levels below 70 or 55 mg/dL, does not harm cognition. In fact, it may protect against dementia, including Alzheimer’s disease. Statins appear to add even more protection. These results reinforce the value of evidence-based, personalized cholesterol management—not only for your heart, but also for your mind.
- Nissen SE, Ni W, Shen X, et al. Low-density lipoprotein cholesterol levels and risk of incident dementia: a distributed network analysis using common data models. J Neurol Neurosurg Psychiatry. Published online March 21, 2025. doi:10.1136/jnnp-2024-334708
About Dr. Gerti Tashko, MD
Dr. Gerti Tashko, MD, is a board-certified endocrinologist based in Montgomery County, Maryland. He is uniquely certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice offers comprehensive, root-cause-focused metabolic and endocrine care, available both virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to optimize long-term health outcomes.




